Clinical Trial Update: Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial update from Alkermes evaluating weight gain using BMI z-score in children with schizophrenia or Bipolar I Disorder; study is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia, Bipolar I Disorder | Phase 3 | Status: RECRUITING